Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Hyaluronic Acid in Knee Osteoarthritis
NCT07666347Recruiting
- Sponsor
- Tanta University
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Trial of botulinum toxin type A and hyaluronic acid in knee osteoarthritis (OA) (2 arms), sponsored by Tanta University. Primary endpoint: Degree of pain at 3 months. Started Jun 2026; status: recruiting.
02
Drugs
botulinum toxin type Ahyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07666347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07666347.